Evidence map›Paper›PMID 15077149›Full record

ReviewOncogene2004

Toxic proteins released from mitochondria in cell death.

Xavier Saelens, Nele Festjens, Lieselotte Vande Walle, Maria van Gurp, Geert van Loo, Peter Vandenabeele

Open access · bronzeAbstract readReview
PubMed Publisher
In one paragraph

Review in Oncogene, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 320 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
320citing papers in PubMed, 1 pooled it
22.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

320 citing papers in PubMed, 1 synthesis or guideline pooled it, 958 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Cell death in glioblastoma and the central nervous system.Cellular oncology (Dordrecht, Netherlands) · 2025
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Host Cell Death and Modulation of Immune Response againstInternational journal of molecular sciences · 2024
    Review
  19. Review
  20. Review

260 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 3 countries.

Xavier SaelensDepartment for Molecular Biomedical Research, VIB and Ghent University, Fiers-Shell-Van Montagu Building, Ghent B9052, Belgium.
Nele Festjens
Lieselotte Vande Walle
Maria van Gurp
Geert van Loo
Peter Vandenabeele
Ghent University · BEEuropean Bioinformatics Institute · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A plethora of apoptotic stimuli converge on the mitochondria and affect their membrane integrity. As a consequence, multiple death-promoting factors residing in the mitochondrial intermembrane space are liberated in the cytosol. Pro- and antiapoptotic Bcl-2 family proteins control the release of these mitochondrial proteins by inducing or preventing permeabilization of the outer mitochondrial membrane. Once released into the cytosol, these mitochondrial proteins activate both caspase-dependent and -independent cell death pathways. Cytochrome c was the first protein shown to be released from the mitochondria into the cytosol, where it induces apoptosome formation. Other released mitochondrial proteins include apoptosis-inducing factor (AIF) and endonuclease G, both of which contribute to apoptotic nuclear DNA damage in a caspase-independent way. Other examples are Smac/DIABLO (second mitochondria-derived activator of caspase/direct IAP-binding protein with low PI) and the serine protease HtrA2/OMI (high-temperature requirement protein A2), which both promote caspase activation and instigate caspase-independent cytotoxicity. The precise mode of action and importance of cytochrome c in apoptosis in mammalian cells has become clear through biochemical, structural and genetic studies. More recently identified factors, for example HtrA2/OMI and Smac/DIABLO, are still being studied intensively in order to delineate their functions in apoptosis. A better understanding of these functions may help to develop new strategies to treat cancer.

Indexed as

ApoptosisAnimalsApoptosis Inducing FactorApoptosis Regulatory ProteinsCarrier ProteinsCaspasesChromatinCytochromes cDNA FragmentationEndodeoxyribonucleasesFlavoproteinsHigh-Temperature Requirement A Serine Peptidase 2HumansIntracellular Signaling Peptides and ProteinsMembrane ProteinsMitochondriaAIFM1 protein, humanApoptosis Inducing FactorApoptosis Regulatory ProteinsCarrier ProteinsCaspasesChromatinCytochromes cDIABLO protein, humanEndodeoxyribonucleasesendonuclease GFlavoproteinsHigh-Temperature Requirement A Serine Peptidase 2HTRA2 protein, humanIntracellular Signaling Peptides and ProteinsMembrane ProteinsMitochondrial ProteinsSerine Endopeptidases

Identifiers

PMID15077149
OpenAlexW2026036357

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.